Literature DB >> 18297262

Influence of continuous veno-venous hemofiltration on argatroban clearance in a patient with septic shock.

N Schusterschitz, R Bellmann, M Stein, S Dunzendorfer, C Pechlaner, M Joannidis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18297262     DOI： 10.1007/s00134-008-1039-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  7 in total

1.  The pharmacokinetics and pharmacodynamics of argatroban: effects of age, gender, and hepatic or renal dysfunction.

Authors:  S K Swan; M J Hursting
Journal:  Pharmacotherapy       Date:  2000-03       Impact factor: 4.705

2.  Heparin-induced thrombocytopenia in patients administered heparin solely for hemodialysis.

Authors:  Patrick T Murray; Marcie J Hursting
Journal:  Ren Fail       Date:  2006       Impact factor: 2.606

3.  Excessive argatroban anticoagulation for heparin-induced thrombocytopenia.

Authors:  Marc G Reichert; Drew A MacGregor; Edward H Kincaid; Sylvia Y Dolinski
Journal:  Ann Pharmacother       Date:  2003-05       Impact factor: 3.154

4.  Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia.

Authors:  Ignatius Y Tang; Donna S Cox; Kruti Patel; Bharathi V Reddy; Linda Nahlik; Sharon Trevino; Patrick T Murray
Journal:  Ann Pharmacother       Date:  2005-01-04       Impact factor: 3.154

5.  Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia.

Authors:  Louis M Guzzi; David A McCollum; Marcie J Hursting
Journal:  J Thromb Thrombolysis       Date:  2006-12       Impact factor: 2.300

6.  Argatroban anticoagulation in critically ill patients.

Authors:  Martin Beiderlinden; Tanja A Treschan; Klaus Görlinger; Jürgen Peters
Journal:  Ann Pharmacother       Date:  2007-04-17       Impact factor: 3.154

7.  Argatroban dosing in intensive care patients with acute renal failure and liver dysfunction.

Authors:  David R Williamson; Isabelle Boulanger; Mariline Tardif; Martin Albert; Geneviève Grégoire
Journal:  Pharmacotherapy       Date:  2004-03       Impact factor: 4.705
  7 in total
  3 in total

1.  Clinical experience with argatroban for heparin-induced thrombocytopenia in a large teaching hospital.

Authors:  Duane Bates; Sarah Griffin; Barb Angel
Journal:  Can J Hosp Pharm       Date:  2009-07

2.  Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.

Authors:  Bernd Saugel; Veit Phillip; Georg Moessmer; Roland M Schmid; Wolfgang Huber
Journal:  Crit Care       Date:  2010-05-20       Impact factor: 9.097

3.  Challenges encountered with argatroban anticoagulation during cardiopulmonary bypass.

Authors:  Shvetank Agarwal; Beth Ullom; Yasser Al-Baghdadi; Michael Okumura
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.